A study in mice has suggested that diabetes drugs may be useful in the treatment of Alzheimer’s disease. The study was published in the journal Neuropharmacology.
A collaboration between researchers at University of Ulster and Lancaster University has investigated whether drugs used in the treatment of type 2 diabetes may protect nerve cells from damage associated with Alzheimer’s in mice bred to develop signs of the disease. One group of mice was treated with a diabetes drug called Lixisenatide, while a second was treated with another diabetes drug called Liraglutide.
READ FULL ARTICLE From Cambridge Network